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Abstract
Background: Accurate	 intraoperative	antibiotic	 redosing	contributes	 to	prevention	
of	surgical	site	infections	in	pediatric	patients.	Ensuring	compliance	with	evolving	na-
tional	guidelines	of	weight‐based,	intraoperative	redosing	of	antibiotics	is	challenging	
to	pediatric	anesthesiologists.
Aims: Our	primary	aim	was	to	increase	compliance	of	antibiotic	redoses	at	the	appro-
priate	time	and	appropriate	weight‐based	dose	to	70%.	Secondary	aims	included	a	
subset	analysis	of	time	compliance	and	dose	compliance	individually,	and	compliance	
based	on	order	entry	method	of	the	first	dose	(verbal	or	electronic).
Methods: At	a	freestanding,	academic	pediatric	hospital,	we	reviewed	surgical	cases	
between	May	1,	2014,	and	October	31,	2017	requiring	antibiotic	redoses.	After	an	
institutional	change	in	cefazolin	dosing	in	May	2015,	phased	interventions	to	improve	
compliance	included	electronic	countermeasures	to	display	previous	and	next	dose	
timing,	an	alert	5	minutes	prior	to	next	dose,	and	weight‐based	dose	recommendation	
(September	2015).	Physical	countermeasures	include	badge	cards,	posting	of	guide-
lines,	and	updates	to	housestaff	manual	(September	2015).	Statistical	process	control	
charts	were	used	 to	 assess	overall	 antibiotic	 redose	 compliance,	 time	 compliance,	
and	dose	compliance.	The	chi‐square	test	was	used	to	analyze	group	differences.
Results: A	total	of	3015	antibiotic	redoses	were	administered	during	2341	operative	
cases	between	May	1,	2014,	and	October	31,	2017.	Mean	monthly	compliance	with	
redosing	was	4.3%	(May	2014‐April	2015)	and	73%	(November	2015‐October	2017)	
(P	<	0.001).	Dose‐only	compliance	increased	from	76%	to	89%	(P	<	0.001),	and	time‐
only	compliance	 increased	from	4.9%	to	82%	(P	<	0.001).	After	 implementation	of	
countermeasures,	electronic	order	entry	compared	with	verbal	order	was	associated	
with	higher	dose	compliance,	90%	vs	86%	(P	=	0.015).
Conclusion: This	quality	improvement	project,	utilizing	electronic	and	physical	inter-
ventions,	was	effective	in	improving	overall	prophylactic	antibiotic	redosing	compli-
ance	in	accordance	with	institutional	redosing	guidelines.
K E Y W O R D S
antibacterial	agents,	antibiotic	prophylaxis,	anti‐infective	agents,	cefazolin,	risk	factors,	
surgical	wound	infection
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1  | INTRODUC TION
1.1 | Problem description
Surgical	 site	 infections	 (SSIs)	are	a	preventable	cause	of	morbidity	
and	mortality	 in	 surgical	 patients.1-3	 Although	 prophylactic	 antibi-
otic	administration	has	been	shown	to	reduce	the	incidence	of	SSIs	
in	both	adults	and	children	undergoing	surgery,	most	local	and	na-
tional	quality	measures	report	only	the	appropriate	timing	and	dose	
of	the	first	antibiotic	given	prior	to	 incision.2-4	However,	maintain-
ing	adequate	 inhibitory	antimicrobial	plasma	and	 tissue	 levels	dur-
ing	surgery	depends	not	just	on	the	initial	dose,	but	also	on	repeat	
dosing.1,5	Though	no	randomized	control	trials	have	investigated	the	
impact	of	 redosing	on	the	 incidence	of	SSIs,	procedure	 length	has	
been	identified	as	an	independent	risk	factor	for	developing	SSIs.3,6,7 
Suboptimal	 redosing	 patterns	 of	 prophylactic	 antibiotics	 during	
longer	pediatric	surgeries	likely	contribute	to	increased	risk	of	SSIs.
1.2 | Available knowledge
The	Centers	for	Disease	Control	(CDC),	Infectious	Disease	Society	of	
America	(IDSA),	and	American	Society	of	Health‐System	Pharmacists	
(ASHP)	 recommend	 intraoperative	 redosing	when	 a	 procedure	 ex-
ceeds	one	to	two	half‐lives	of	the	antibiotic,	when	there	is	major	blood	
loss,	or	when	a	patient	has	extensive	burns.3,5	The	recommended	re-
dosing	intervals	for	commonly	used	antibiotics	for	surgical	prophy-
laxis	were	 updated	 in	 2013	 by	 the	AHSP.5 Traditional educational 
interventions,	 such	 as	 email	 correspondence	 or	 announcements,	
have	been	shown	to	be	 ineffective	 in	achieving	 reliable	adherence	
to	antibiotic	redosing	guidelines,	with	studies	reporting	compliance	
below	50%	in	some	settings.8,9	Because	redosing	guidelines	are	fre-
quently	revised	by	expert	societies,	lack	of	routine	compliance	meas-
urement	results	in	challenges	to	reliably	adjusting	practice	habits.
1.3 | Rationale
Given	the	lack	of	successful	practice	transformation	using	traditional	
methods,	coupled	with	the	widespread	implementation	of	anesthe-
sia	electronic	medical	records	(EMRs),	we	utilized	clinical	 informat-
ics	to	drive	a	quality	improvement	project	to	optimize	intraoperative	
antibiotic	redosing	after	an	institutional	guideline	revision.	By	lever-
aging	the	preexisting	standard	work	of	surgeons,	pharmacists,	and	
anesthesiologists,	and	utilizing	antibiotic‐specific	timed	alerts	in	the	
EMR,	we	designed	a	process	to	 improve	the	accuracy	of	dose	and	
timing	of	intraoperative	antibiotic	redoses.
1.4 | Specific aims
The	primary	aim	of	this	project	was	to	increase	appropriate	dose	and	
time	of	intraoperative	redosing	to	70%	compliance.	The	secondary	
aims	examined	dose	and	timing	of	redose	independently	and	also	the	
accuracy	of	antibiotic	redoses	when	given	as	electronic	compared	to	
verbal	orders.
2  | MATERIAL S AND METHODS
2.1 | Context
After	the	Institutional	Review	Board	approved	a	waiver	for	this	im-
provement	 project,	 it	 was	 initiated	 by	 an	 interdisciplinary	 quality	
improvement	 team	 at	 a	 311‐bed,	 freestanding	 academic	 pediatric	
hospital	with	seven	operating	rooms	and	12	off‐site	procedure	loca-
tions.	Academic	faculty,	fellows,	residents,	nurse	practitioners,	and	
physician	assistants	from	anesthesia	and	surgery	departments	pro-
vide	care	for	surgical	patients.	The	institution	utilizes	an	EMR	(EPIC).
Inclusion	 criteria	 were	 those	 patients	 who	 underwent	 proce-
dures	at	 least	2	hours	 in	duration	and	 received	at	 least	one	 intra-
operative	 dose	 of	 antibiotic	 between	 May	 1,	 2014,	 and	 October	
31,	2017,	 including	unscheduled	urgent	and	emergent	procedures.	
Exclusion	criteria	were	those	patients	who	(a)	received	prophylactic	
antibiotics	requiring	greater	than	6‐hour	redosing	since	they	repre-
sent	a	small	percentage	of	antibiotics	used	for	surgical	prophylaxis	
and	their	redosing	recommendations	may	vary	based	on	organ	func-
tion	or	plasma	levels,	(b)	received	multiple	antibiotics	from	the	same	
class	 (such	as	 cefazolin	administered	at	 case	 start	 followed	by	ce-
foxitin),	(c)	received	an	antibiotic	class	change	during	the	procedure,	
and	(d)	did	not	have	a	weight	recorded	in	the	EMR	on	day	of	surgery.
2.2 | Intervention
2.2.1 | Current state
After	 the	 AHSP	 guidelines	 were	 updated	 in	 2013,	 our	 Antibiotic	
Stewardship	Committee	updated	 institutional	 guidelines,	 including	
a	change	in	cefazolin	dose	from	20	to	30	mg/kg	in	May	2015.	While	
the	AHSP	 guidelines	 suggest	 redosing	 of	 cefazolin	 every	 4	 hours,	
our	 Antibiotic	 Stewardship	 Committee	 recommended	 redosing	
every	3	hours	due	to	cefazolin	half‐life	of	1.2‐2.2	hours	to	comply	
with	the	recommendation	to	redose	every	one	to	two	half‐lives	of	
What is already known
•	 Maintaining	a	 therapeutic	plasma	 level	of	prophylactic	
antibiotics	throughout	surgical	procedures	is	important	
for	 prevention	 of	 surgical	 site	 infections	 in	 pediatric	
patients.
•	 Given	 evolving	 antibiotic	 redosing	 recommendations,	
traditional	methods	for	ensuring	reliable	intraoperative	
redose	compliance	may	be	ineffective.
What this article adds
•	 Countermeasures	 integrated	 into	 the	 electronic	 anes-
thesia	record	are	effective	in	improving	pediatric	anes-
thesiologists’	 compliance	 with	 institutional	 guidelines	
for	redosing	of	surgical	prophylactic	antibiotics.
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an	antibiotic	and	the	evidence	that	SSI	rates	are	significantly	higher	
when	 a	 single	 dose	 is	 used	 for	 procedures	 longer	 than	3	hours	 in	
duration.3,5	Current	state	analysis	revealed	high	compliance	of	ap-
propriate	 initial	 preoperative	dose	and	 timing	due	 to	utilization	of	
electronic	order	entry	and	pharmacist	preparation.9	However,	intra-
operative	 antibiotic	 redose	 and	 timing	was	 suboptimal,	with	 a	 4%	
baseline	compliance	(May	2014‐April	2015).	Because	subsequent	in-
traoperative	doses	were	prepared	and	administered	by	the	anesthe-
siologist,	not	the	pharmacist,	a	key	driver	for	high	compliance	was	
determined	to	be	anesthesiologist	accessibility	to	the	new	redosing	
guidelines	(Figure	1).
2.2.2 | Countermeasures
Electronic	 countermeasures	 based	 on	 the	 EMR	 optimization	 key	
driver	 included	 the	 following:	 (a)	An	electronic	 reminder	displayed	
on	the	left	side	of	the	anesthesia	record	with	the	name	of	the	last	
antibiotic	 administered	 and	 time	 due	 of	 the	 next	 antibiotic	 dose	
based	 on	 the	 revised	 redosing	 guidelines	 (Figure	 2A);	 (b)	 another	
electronic	 display	 in	 the	 right	 column	 continuously	 displayed	 the	
antibiotic	given	and	time	since	the	last	dose	(Figure	2B);	(c)	clicking	
on	reminders	opened	a	display	with	the	weight‐based	dose	for	that	
antibiotic	prepopulated	in	the	anesthesia	medication	administration	
record	(Figure	2C);	(d)	an	additional	electronic	best	practice	pop‐up	
alert	provided	a	reminder	5	minutes	prior	to	the	time	of	each	redose	
(Figure	2D).	These	electronic	countermeasures	were	implemented	in	
September	2015.
Physical	 countermeasures	 based	 on	 the	 point‐of‐care	 physical	
reference	guidelines	key	driver	 included	the	following:	 (a)	distribu-
tion	 of	 antibiotic	 redose	 guideline	 badge	 cards	 to	 anesthesia	 pro-
viders,	(b)	posting	of	redosing	guidelines	on	the	operating	room	wall	
behind	 the	 anesthesia	 supply	 cart,	 and	 (c)	 updating	 the	 hospital's	
F I G U R E  1  Diagram	of	key	drivers Key Drivers
EMR Opmizaon
Clear communicaon 
of process change
Point of care physical 
reference guidelines
Reliable process measure 
of compliance
Intervenons
Pop up redosing alert with link to guidelines
Calculated mg/kg and total dose under medicaon tab
Connuous displayed message of me of last anbioc 
administered in right paent info column
Time of next anbioc dose and frequency in le reminder column
Physician badge with guidelines
Guidelines posted in operang room
Updated hospital anmicrobial housestaff manual
Presented new guidelines at anesthesia and pharmacy division 
meengs
Developed electronic EMR query for data acquision
F I G U R E  2  Electronic	countermeasures	
for	antibiotic	redosing.	Electronic	
reminder	displayed	continuously	on	
the	left	side	of	the	screen	with	name	
of	antibiotic	and	time	of	next	indicated	
redose	(A);	time	of	last	antibiotic	and	
dose	given	continuously	displayed	on	the	
right	side	of	the	screen	(B);	medication	
administration	window	that	links	directly	
from	the	alert	(D)	and	suggests	doses	of	
last	dose	given	and	patient's	weight‐based	
dose	from	guidelines	(C);	pop‐up	alert	to	
remind	provider	5	min	prior	to	time	of	
next	redose	(D)
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antimicrobial	house	staff	manual.	These	displays	included	the	redos-
ing	frequency,	weight‐based	dose,	and	maximum	dose	for	common	
surgical	prophylactic	antibiotics.	These	interventions	were	phased,	
concluding	in	September	2015.
2.2.3 | Implementation
To	ensure	clear	communication	of	the	process	change,	another	key	
driver,	 updates	made	by	 the	Antibiotic	 Stewardship	Committee	 to	
the	surgical	antibiotic	prophylaxis	guidelines	were	emailed	out	to	the	
perioperative	team	and	presented	at	interdisciplinary	meetings	(July	
2015).	A	report	of	antibiotic	electronic	order	entry	compliance	was	
emailed	monthly	to	surgical	chiefs	after	implementation.	Incremental	
feedback	of	improvement	efforts	was	provided	to	department	mem-
bers	in	the	form	of	statistical	process	control	(SPC)	charts	through-
out	the	intervention,	which	was	developed	in	order	to	address	the	
final	key	driver,	a	reliable	process	measure	of	compliance.
2.2.4 | Measures
Patient	characteristics	 (age,	weight),	order	entries,	and	medication	
administration	records	were	electronically	obtained	from	the	EMR.	
The	primary	outcome	was	compliance	with	administration	of	antibi-
otic	redose	at	both	the	appropriate	time	(±15	minutes)	and	appro-
priate	dose,	defined	as	 the	patient's	 calculated	weight‐based	dose	
(±10%)	until	maximum	dose	was	reached.	Maximum	dose	and	redose	
interval	adjustments	were	made	for	certain	antibiotics	in	neonates	
(Table	1).	A	dose	was	considered	compliant	if	it	first	met	criteria	for	
appropriate	 time	 and	 then	 for	weight‐based	dose.	 Secondary	out-
comes	examined	were	(a)	time	compliance	only,	(b)	dose	compliance	
only,	and	 (c)	 compliance	between	 redoses	after	 the	 first	dose	was	
ordered	via	electronic	order	entry	compared	to	those	administered	
after	 verbal	 order	 between	 surgeon	 and	 anesthesiologist.	We	 set	
a	goal	of	 achieving	and	maintaining	70%	compliance	 for	 antibiotic	
redoses.
2.3 | Analysis
A	 SPC	 chart	 was	 used	 to	 display	 compliance	 of	 antibiotic	 redose	
administration	 time	 and	 dose	 for	 all	 cases	 by	month.	Center	 lines	
(CL),	 representing	 average	 compliance,	 were	 displayed	 to	 demon-
strate	responses	to	countermeasures.	Upper	and	lower	control	limits	
were	included	on	the	charts,	and	breaks	in	the	CL	were	at	times	of	
special	cause	variation	attributed	to	nonrandom	conditions	per	the	
Western	Electric	Rules.10,11	There	are	several	rules	for	special	cause	
variation,	and	the	basic	four	are	as	follows:	Rule	1—a	point	outside	of	
three	standard	deviations	from	the	same	side	of	the	centerline	is	not	
due	 to	common	cause	variation;	Rule	2—two	of	 three	consecutive	
points	that	fall	beyond	two	standard	deviations	on	the	same	side	of	
the	centerline	are	not	due	to	common	cause	variation;	Rule	3—four	
of	 five	consecutive	points	 that	 fall	beyond	one	standard	deviation	
on	 the	 same	 side	 of	 the	 centerline	 are	 not	 due	 to	 common	 cause	
variation;	and	Rule	4—nine	consecutive	points	that	fall	on	the	same	
side	of	the	centerline	are	not	due	to	common	cause	variation.	Data	
were	 collected	 and	 analyzed	using	Microsoft	Excel,	 and	 statistical	
analyses	 were	 performed	 using	 R	 version	 3.4.3.	 Chi‐square	 tests	
were	used	to	determine	statistical	significance	of	group	differences,	
with	P	<	0.05	considered	statistically	significant.	The	pre‐interven-
tion	 group	 was	 comprised	 of	 cases	 between	 May	 2014	 through	
July	2015,	 and	 the	post	 intervention	group	 included	August	2015	
through	October	2017.
2.4 | Ethical considerations
No	notable	conflicts	of	interest	were	identified	in	the	carrying	out	
of	this	project.	Ethically,	we	did	consider	that	improved	reliance	on	
electronic	reminders	for	antibiotic	redosing	could	potentially	prompt	
a	provider	to	administer	too‐frequent	dosing	of	an	antibiotic	in	pa-
tients	who	require	an	alternative	dosing	schedule,	such	as	those	with	
compromised	renal	function,	since	pharmacists	do	not	review	intra-
operative	medications	 prior	 to	 administration,	 and	 that	 this	 could	
result	in	potential	harm.
3  | RESULTS
Between	May	 1,	 2014,	 and	October	 31,	 2017,	 there	were	 2685	
operative	cases	potentially	requiring	redoses.	After	application	of	
exclusion	criteria	(93	cases	were	spurious	data	that	did	not	meet	
inclusion	criteria,	90	cases	lacked	weight,	65	cases	received	anti-
biotic	redoses	greater	than	6	hours	apart,	41	cases	had	an	intraop-
erative	antibiotic	class	change,	11	cases	received	antibiotics	from	
the	 same	 class,	 and	 two	procedures	 lacked	 a	 start	 or	 end	 time),	
2338	out	of	17	735	cases	(13%)	were	included	in	the	analysis	and	
there	were	2952	antibiotic	 redoses	administered	 in	 the	 included	
cases.
3.1 | Primary Aim
3.1.1 | Overall antibiotic redose compliance
Mean	 percentage	 monthly	 compliance	 with	 antibiotic	 redosing	 at	
both	 the	 correct	 time	 and	 correct	 dose	 is	 represented	 by	 the	 CL	
(Figure	 3).	 The	 mean	 compliance	 began	 at	 4.3%	 (May	 2014‐April	
2015)	and	rose	to	73%,	with	the	establishment	of	a	new	CL	(CL	#3,	
November	 2015‐October	 2017),	P	 <	 0.001,	 surpassing	 our	 short‐
term	target	of	70%	of	antibiotic	 redoses	given	at	 the	correct	 time	
and	correct	dose.
3.2 | Secondary Aims 1 and 2
3.2.1 | Dose compliance only and time 
compliance only
Dose	compliance	for	any	antibiotic	redose	administered,	regardless	
of	timeliness,	increased	from	76%	(CL	#1)	to	89%	(CL	#3),	P	<	0.001,	
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and	 time	 compliance	 for	 any	 antibiotic	 redose,	 regardless	 of	 dose	
administered,	increased	from	4.9%	(CL	#1)	to	82%	(CL	#3),	P < 0.001 
(Figure	4A,	4B).
3.3 | Secondary Aim 3
3.3.1 | Electronic vs verbal order compliance
For	1362	redoses,	an	electronic	order	was	placed	prior	to	the	opera-
tion	by	the	surgeon	for	the	 initial	antibiotic	dose	to	be	prepared	by	
the	 pharmacist.	 The	 remaining	 1590	 redoses	were	 administered	 to	
patients	after	the	surgeon	verbally	gave	the	order	to	the	anesthesi-
ologist.	 Pre‐intervention,	 prior	 to	 July	 2015,	 electronic	 order	 entry	
was	associated	with	significantly	higher	compliance	for	time	and	dose	
combined,	time	only,	and	dose	only,	P	<	0.05.	Postintervention,	elec-
tronic	 order	 entry	 impacted	only	 the	dose	of	 antibiotic	 given,	with	
90%	compliance	observed	for	redoses	given	after	an	electronic	order,	
compared	with	86%	compliance	for	those	ordered	verbally	(P	=	0.015).
4  | DISCUSSION
4.1 | Summary
To	the	authors’	knowledge,	this	 is	the	first	description	of	a	quality	
improvement	project	to	increase	compliance	with	appropriate	intra-
operative	antibiotic	redosing	guidelines	for	pediatric	surgeries.	This	
project	demonstrates	the	effectiveness	of	a	multifaceted	interven-
tion,	 including	 timed	electronic	 alerts	displayed	on	 the	 anesthesia	
provider's	EMR	and	cognitive	aids,	resulting	in	an	18‐fold	increase	in	
redose	compliance.	This	is	significant	given	the	morbidity	associated	
with	SSIs	and	the	role	that	timely	and	accurately	dosed	antibiotics	
have	in	maintaining	therapeutic	plasma	levels.5	By	leveraging	stand-
ard	workflow,	we	 successfully	 created	 a	 process	 that	 did	 not	 just	
result	 in	 a	 temporary	 compliance	 improvement	 but	 demonstrated	
sustainability	for	nearly	2	years.
4.2 | Interpretation
In	order	 to	determine	whether	 there	were	differences	between	
which	factors	were	contributing	to	compliance	(dose	or	time),	we	
also	 examined	 intraoperative	 compliance	 independently.	 Timing	
of	redoses	had	a	 larger	 increase	 in	compliance,	 likely	due	to	the	
electronic	and	physical	countermeasures	described.	The	weight‐
based	 dose	 compliance	 increased	 significantly	 but	 without	 the	
magnitude	 of	 the	 timing	 increase	 in	 compliance,	 indicating	 that	
timing	was	a	more	significant	barrier	to	compliance.	Dose	compli-
ance	of	subsequent	redoses	was	higher	when	an	electronic	order	
was	placed	for	the	first	antibiotic	dose.	The	EMR	alerts	reminded	
providers	of	the	correct	antibiotic	dose	and	appropriate	time	for	
redosing,	 regardless	of	whether	 the	 first	dose	was	ordered	ver-
bally	or	electronically.	Also,	 the	medication	administration	pop‐
up	included	weight‐based	dosing	guidance	alongside	the	previous	
dose.
Surgeons	perform	nearly	one	million	pediatric	operations	each	
year	in	the	United	States,	with	a	reported	SSI	incidence	of	2%‐5%.12 
Given	that	approximately	half	of	surgical	site	infections	are	prevent-
able	with	 appropriate	 antibiotic	prophylaxis,	 optimization	of	 intra-
operative	antibiotic	redosing	has	the	potential	to	reduce	morbidity	
and mortality.3,10,13,14	 Although	 duration	 of	 surgery	 greater	 than	
2	 hours	 has	 been	 identified	 as	 an	 independent	 factor	 for	 SSI,	 the	
Surgical	Care	Improvement	Project	(SCIP)	and	CDC	guidelines	focus	
only	on	reporting	appropriate	first,	preoperative	dose	of	antibiotic,	
not	subsequent	 intraoperative	redoses.6,7	Because	bolus	dosing	of	
an	antibiotic	results	in	a	peak	and	trough	of	plasma	levels,	there	is	a	
high	risk	of	falling	below	the	minimal	inhibitory	concentration	(MIC)	
in	longer	surgeries	when	redosing	is	delayed	or	neglected,	and	cur-
rent	evidence	does	demonstrate	that	cefazolin	levels	fall	below	the	
MIC	prior	to	4	hours	after	a	first	dose.13	Maintaining	the	therapeutic	
plasma	and	tissue	levels	required	to	prevent	infection	in	surgeries	of	
this	duration	requires	appropriate	redosing	based	on	the	half‐life	of	
antibiotic	given.
Antibiotic Dose (mg/kg) Max dose Age‐based OR redose
Ampicillin 50 2	g <14	d	OR	<2	kg:	6	h
>15	d	AND	>2	kg:	3	hrs
Ampicillin‐Sulbactam 50 2	g <1	mo:	contact	pharmacy
>1	mo:	3	h
Cefazolin 30 <120	kg:	2	g <7	d	OR	<2	kg:	6	h
>120	kg:	3	g >7	d	AND	>2	kg:	3	h
Cefotaxime 50 2	g <7	d	OR	<2	kg:	8	h
>7	d	AND	2	kg:	6	h
>1	mo:	3	h
Cefoxitin 40 2	g <1	mo:	3	h
>1	mo:	2	h
Clindamycin <1 mo: 5 900	mg <7	d	OR	<2	kg:	12	h
>1 mo: 10 >7	d	OR	>2	kg:	6	h
TA B L E  1  Antibiotic	redose	guidelines	
for	surgical	prophylaxis	as	determined	by	
our	institution's	antibiotic	stewardship	
committee
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4.3 | Limitations
This	project	had	several	limitations.	First,	as	a	quality	improvement	
project	with	multiple	countermeasures,	it	is	possible	that	increased	
provider	awareness	and	altered	practice	habits	 contributed	 to	 the	
results	and	not	the	countermeasures	described.	However,	given	the	
temporal	relationship	between	countermeasure	deployment	and	in-
crease	in	compliance,	we	find	this	to	be	unlikely.	Second,	compliance	
with	utilization	of	individual	countermeasures	was	not	measured.	It	
is	unknown	which	countermeasures	contributed	more	to	the	results	
since	multiple	countermeasures	were	initiated	simultaneously.	Third,	
our	electronic	reporting	algorithm	did	not	provide	nontemporal	in-
dications	for	antibiotic	redosing,	such	as	large‐volume	blood	loss	or	
burn	physiology,	which	can	alter	plasma	levels	of	an	antibiotic.
While	our	antibiotic	redose	compliance	reached	our	stepwise	aim	
of	70%	compliance,	the	long‐term	goal	of	this	quality	improvement	
initiative	 is	 full	 compliance.	 Future	 efforts	 will	 seek	 to	 determine	
unknown	barriers	to	achieving	full	compliance	and	could	explore	an	
association	between	low	plasma	levels	of	antibiotic	with	 increased	
infection	 risk.	 Next	 steps	 should	 consider	 robust	 alerts	 with	 the	
ability	to	open	in	front	of	any	window	on	the	anesthesia	computer	
screen	or	adding	an	audible	alert	when	a	redose	 is	due.	Given	the	
high	morbidity	associated	with	SSIs,	monitoring	of	intraoperative	an-
tibiotic	redosing	compliance	should	be	considered	by	practitioners	
seeking	to	reduce	the	risk	of	SSIs.
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F I G U R E  3  Statistical	process	control	
chart	for	overall	antibiotic	redose	
compliance	by	month,	defined	as	by	
administration	of	the	correct	weight‐
based	dose	at	the	indicated	time	for	
redosing.	Arrows	on	x‐axis	represent	
institutional	change	in	redosing	guidelines	
(May	2015)	and	completion	of	phased	
interventions,	including	physical	and	
electronic	countermeasures	(September	
2015)
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F I G U R E  4  Antibiotic	redose	compliance	by	time	only	(A)	and	dose	only	(B).	Arrows	on	x‐axis	represent	institutional	change	in	redosing	
guidelines	(May	2015)	and	completion	of	phased	interventions,	including	physical	and	electronic	countermeasures	(September	2015)
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